Alogliptin Use in Elderly People: A Pooled Analysis from Phase 2 and 3 Studies

@article{Pratley2009AlogliptinUI,
  title={Alogliptin Use in Elderly People: A Pooled Analysis from Phase 2 and 3 Studies},
  author={R. Pratley and T. McCall and P. Fleck and Craig A. Wilson and Q. Mekki},
  journal={Journal of the American Geriatrics Society},
  year={2009},
  volume={57}
}
OBJECTIVES: To compare the efficacy and safety of alogliptin, a dipeptidyl peptidase‐4 (DPP‐4) enzyme inhibitor, in elderly (≥65) and younger (<65) patients with type 2 diabetes mellitus. 

Paper Mentions

Interventional Clinical Trial
The purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily (QD), combined with pioglitazone in adults with type 2 diabetes mellitus  
ConditionsDiabetes Mellitus
InterventionDrug
Interventional Clinical Trial
The purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily (QD), in adults with type 2 diabetes.  
ConditionsDiabetes Mellitus
InterventionDrug
Interventional Clinical Trial
The purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily (QD), combined with a sulfonylurea in adults with type 2 diabetes mellitus.  
ConditionsDiabetes Mellitus
InterventionDrug
Interventional Clinical Trial
The purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily (QD), combined with metformin in adults with type 2 diabetes mellitus.  
ConditionsDiabetes Mellitus
InterventionDrug
Predictors of response to dipeptidyl peptidase‐4 inhibitors: evidence from randomized clinical trials
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 34 REFERENCES
Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy
Individual Sulfonylureas and Serious Hypoglycemia in Older People
Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics and DPP‐4 inhibitors
Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus
Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus
DPP‐4 inhibitors and their potential role in the management of type 2 diabetes
  • A. Barnett
  • Medicine
  • International journal of clinical practice
  • 2006
...
1
2
3
4
...